Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-947K
-
Total reported value, excl. options
-
$34.7M
-
Value change
-
-$1.84M
-
Put/Call ratio
-
0.21
-
Number of buys
-
14
-
Number of sells
-
-22
-
Price
-
$1.84
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2023
59 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2023.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 52.3M outstanding shares and own 36.04% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (2.7M shares), TANG CAPITAL MANAGEMENT LLC (2.3M shares), VANGUARD GROUP INC (1.73M shares), DIMENSIONAL FUND ADVISORS LP (1.27M shares), Potomac Capital Management, Inc. (1.05M shares), BlackRock Inc. (998K shares), FULLER & THALER ASSET MANAGEMENT, INC. (986K shares), Roumell Asset Management, LLC (681K shares), and GEODE CAPITAL MANAGEMENT, LLC (338K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.